| symbol | subject | date & time | rating |
|
|
I think you're right SKG about the chart bounce back. Some interesting buying has returned to ICO, ever since the 500k share cross last week. I anticipate a gradual price increase as we march towards the PII results. More interesting would be... |
3/5/2013 7:27:25 AM |
4 |
|
|
Hey MMN, Is this the the Lucentis Study? http://www.clinicaltrials.gov/ct2/show/results/NCT00284050?term=Lucentis&recr=Completed&rslt=With&phase=1&rank=3 |
1/3/2013 9:28:44 AM |
3 |
|
|
So if 149 patients is statistically significant, why does the study require 208 patients? It doesn't. ICO's telegraphing that the study can be completed without any new patients. Enrolling patients can sometimes be a bottleneck for study ... |
1/3/2013 9:03:04 AM |
4 |
|
|
We broke throught the major resistance at .73 and now testing the next one at .78. Happy holidays. TB technicalbuy.com |
12/24/2012 11:39:40 AM |
5 |
|
|
My answer to you pmrider is I bought more shares today! YM's $500m takeover deal is fantastic news for the Canadian biotechs. Bioasis is one of the most exciting stories in this young bull market and as such it is one of the best buying oppor... |
12/12/2012 4:13:59 PM |
5 |
|
|
Hi folks, the biotech bull has oficially rung it's bell. With the YM deal announced today the interest in CDN biotechs is about to go to a new level. ICO's measely $40m Mcap makes ICO an extremely attractive phII company. 2013 will be a f... |
12/12/2012 4:02:04 PM |
4 |
|
|
The answer is yes. There are many examples out there. Take a look at the deal between Seattle Genetics and Abbott.pmrider once said "...point about the early stage is also understood, but you need to consider the recent Alexion-Enobia transaction ... |
10/21/2012 10:16:16 PM |
4 |
|
|
After reading that article I almost wish ICO had kept the asset and done the same thing Immune is doing now. From what I understand that 6% piece that ICO owns is non-dilutive....so the the ratio remains constant post-financing. In the financing ... |
10/13/2012 7:59:37 AM |
3 |
|
|
ICO posted a corporate update this am. Three key points: 1 ico confirmed that recruitment on track to be completed by end of year 2 confirmed interim data by end of year 3 last question in the FAQ section on the idealstudy.org hints at positive... |
10/10/2012 11:25:47 AM |
4 |
|
|
So THE biggest eye conf is coming up in Chicago on Nov 10-13....If we are to get any interim data this year this would be the best venue. That only a month away. Which means anticipatory buying is sure to drive up the price in a hurry. Good tim... |
10/3/2012 11:52:46 PM |
3 |
|
9/5/2012 7:22:48 AM
| 4038 reads
| overall quality: 3
I believe the junior gold market is poised for a great run and I believe now is the time to get back into your favorite gold plays. In September of 2011 I told my subscribers that the resource market was full of fear and uncertainty. I stopped i...
7/10/2012 2:29:34 AM
| 1497 reads
| 1 comments
| overall quality: 3
The biotech bull market is rapidly growing. For the past two years I've been carefully looking out for the signs of the biotech bull. This year the signs are coming by a truckload. Every week there is either an M&A deal or some sort of ...
12/30/2011 2:09:11 PM
| 3865 reads
| 2 comments
| overall quality: 3
Bioasis (BTI.V) is my favorite stock at the moment because it will have a catalyst rich 2012 that may send this stock soaring for a 5 to 10 bagger return potential. I've been raving about Bioasis technology potential for a while now. Over the...
11/24/2011 9:31:54 AM
| 1362 reads
| overall quality: 3
Bioasis' Transcend program attracts the first big Pharma. Notice this is more then a collab agreement. This is an option to license the product. Transcend has been independently verified as efficacious in delivering biologics across teh blood brai...
8/26/2011 10:55:35 AM
| 2058 reads
| overall quality: 4
Good things happen to those who patiently sit in a good investment!Cameco Corp. (CCO-T) is making a $520-million hostile takeover bid for Hathor Exploration Ltd. (HAT-T), sending the junior uranium company’s stock soaring in heavy trading after ma...
8/26/2011 10:45:21 AM
| 1798 reads
| overall quality: 3
The Ontario Securities Commission has ordered senior officers and directors of Sino-Forest Corp (TRE-T 4.81). to resign and has cease-traded the company’s shares.The commission said in a release Friday that it has reason to believe the company and...
8/16/2011 9:29:19 AM
| 1396 reads
| overall quality: 3
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */table.MsoNormalTable{mso-style-name:"Table Normal";mso-tstyle-rowband-size:0;mso-tstyle-colband-size:0;mso-style-noshow:yes;mso-style-priority:99;mso-style-qf...
8/16/2011 8:17:39 AM
| 2810 reads
| overall quality: 3
TechnicalBuy.ComRecent developments have spooked a lot of investors and brought a lot of uncertainty into the markets. There are a lot of opinions out there as to whether the stocks are oversold or whether they will go lower still. For my part I h...
8/5/2011 6:26:01 AM
| 1904 reads
| 1 comments
| overall quality: 4
Anonymity does not mean immunity. Augen Gold Corp. and its chiefexecutive officer, David Mason, have won a court order directingStockhouse Publishing Ltd. to help identify three forum posters thatAugen and Mr. Mason are suing for defamation. The o...
8/4/2011 8:35:57 AM
| 1813 reads
| overall quality: 3
I like CKR.V and NKL.V here on the news of a monster deposit. NKL's Wellgreen deposit is open to extension and CKR has scooped up land right next to NKL.NKL came down on some weakness recently following some questions about the way its 43-101 was ...
Stockhouse.com: Taking
it to the street
